Select Location
What is your delivery location?
We need your delivery location to continue browsing
Select Location
We need your delivery location to continue browsing
Prescription Required
cipla
30 tablet
Efavirenz, Emtricitabine and Tenofovir Disoproxil Fumarate
Keep in cold place
Delivering To:
Overview
Viraday (Emtricitabine + Tenofovir disoproxil fumarate + Efavirenz) tablet is a combination of three antiretroviral medications. It is used for the treatment of HIV (human immunodeficiency virus) infection. This medication belongs to a class of medications known as nucleoside reverse transcriptase inhibitors (NRTIs). Viraday tablet boosts your immune system to fight against infection and helps to reduce the amount of HIV in your body, and improves the quality of life. It is important to take the Viraday tablet as prescribed by your doctor. Do not take this medicine in the wrong way, as it may lead to some serious side effects.
HIV
HIV infection
The following are the possible side effects that can occur during your treatment with Viraday tablet. Contact your medical practitioner immediately if any of the above-mentioned side effects appear.
Dizziness
Unusual sweating
Skin rash
Itching
Indigestion
Constipation
Redness of skin
Headache
Taste change
Blurred vision
Fever
Confusion
Chills
Nightmare
Viraday tablet is a combination of three anti-HIV medicines: Emtricitabine, Tenofovir disoproxil fumarate, and Efavirenz. This medication is not a permanent cure for HIV infection. It only prevents the multiplication of HIV (human immunodeficiency virus) infection in human cells. The recommended dose of Viraday medicine is decided by a doctor according to your previous medical condition and response to the treatment. It is advisable not to change your regular dosing schedule without taking suggestions from your doctor. If you experience any signs and symptoms while receiving the Viraday tablet, inform your doctor immediately.
Three active components make up Viraday Tablet-
Efavirenz (600 mg): Efavirenz functions as a non-nucleoside reverse transcriptase inhibitor (NNRTI) by attaching itself to the HIV-1 reverse transcriptase enzyme and preventing it from functioning. This stops viral RNA from being converted into DNA, which is an essential stage in HIV replication.
Emtricitabine (200 mg): A nucleoside reverse transcriptase inhibitor (NRTI) is Emtricitabine, which is phosphorylated inside cells, where it competes with natural nucleosides and joins the expanding viral DNA chain, causing the chain to break.
Tenofovir disoproxil fumarate (300 mg): This medication is an NRTI, just like emtricitabine. It integrates into the viral DNA chain after phosphorylation, leading to termination.
Alcohol
unsafe
Do not consume alcohol while taking Viraday tablet.
Pregnancy
consult your doctor
Considering there is clear evidence of a risk to the unborn, Viraday Tablet should not be used during pregnancy. In certain life-threatening circumstances, however, if the advantages are greater than the possible hazards, the doctor might sometimes recommend it. Please speak with your physician.
Breast Feeding
consult your doctor
Viraday Tablets are most likely safe to take while breastfeeding if prescribed. According to a few studies, the medication poses no serious risks to the developing baby.
Driving
danger
Viraday tablet can cause drowsiness, dizziness, or a reduction in attention. If you experience these symptoms, don't drive. It is advisable not to drive or operate heavy machinery, you may feel dizzy as one of the side effects of Viraday.
Kidney
precaution
Patients with kidney disease can possibly use Viraday Tablet. According to the few data available, these patients may not require a dose modification for Viraday Tablet. Please speak with your physician.
Liver
precaution
Patients with liver conditions can likely safely consume Viraday Tablet. According to the little data available, these patients may not require a dose modification for Viraday Tablet. Please speak with your physician
It is advisable not to miss a dose. If you miss a scheduled dose of Viraday tablets, contact your doctor immediately.
Viraday tablet is an antiviral medication that prevents the human immunodeficiency virus (HIV) from multiplying in your body. Viraday tablet also helps to delay the production of HIV infection and improve the quality of life.
Some common side effects are:- fatigue, headache, nausea, taste change, stomach ache, diarrhea, fever, chills, blurred vision, weight loss, abnormal dreams, etc.
This medication helps boost your immune system to fight against infection. It also helps to delay the production of HIV infection.
If you miss a scheduled dose of the Viraday tablet, contact your doctor immediately.
It is available in the strength of 200mg/300mg/600mg.
Before using this medication, speak with your doctor if you have a history of liver or renal illness, mental health issues, seizures, or pregnancy.
Make an immediate call to your local poison control center or emergency room if you suspect there was an overdose. signs of a severe medication reaction are Wheezing, tightness in the chest, fever, itching, a nasty cough, blue or gray skin, convulsions, or swelling of the face, lips, tongue, or neck are some of these symptoms.
At our pharmacy, your health is our top priority. All of our medicines are safe, effective, and approved by leading health authorities. We partner exclusively with reliable and reputable manufacturers, ensuring the highest quality standards in every product we deliver.
Enjoy the convenience of fast home delivery, secure packaging, and affordable prices*—plus *special discounts on bulk orders. We’re proud to offer international shipping to a wide range of countries across Asia, Europe, Africa, the Americas, and beyond, making trusted healthcare accessible no matter where you are.
Whether you're a patient or a healthcare provider, you can order with confidence and compassion. Our goal is to ensure that quality healthcare reaches everyone, everywhere.
We currently ship to:
Barbados, Haiti, Trinidad and Tobago, Mexico, Bahamas, Ecuador, Peru, Chile, Brazil, Colombia, Philippines, U.K., USA, Kuwait, Saudi Arabia, UAE, Oman, Qatar, Japan, Ireland, Russia, China, France, Australia, Lithuania, Nigeria, Romania, Algeria, Canada, Singapore, Thailand, Hong Kong, Bahrain, Jordan, Indonesia, Hungary, Moldova, Bulgaria, Azerbaijan, Congo, Ethiopia, Lebanon, Morocco, Mozambique, South Korea, Sri Lanka, Belarus, Mongolia, Malaysia, Vietnam, Tunisia, Zambia, and Israel.
Experience the quality everyone’s talking about – order today!
Arribas, J. R., Pozniak, A. L., Gallant, J. E., Dejesus, E., Gazzard, B., Campo, R. E., et al. (2008). Tenofovir disoproxil fumarate, emtricitabine, and efavirenz versus zidovudine/lamivudine and efavirenz in antiretroviral‑naïve patients: virologic, immunologic, and morphologic changes—a 96‑week analysis. Journal of Acquired Immune. Deficiency Syndromes, 47(1), 74–81.
Author(s) unspecified. (2017). Efficacy and safety of a once‑daily single‑tablet regimen of tenofovir, lamivudine, and efavirenz assessed at 144 weeks among antiretroviral‑naïve and experienced HIV‑1‑infected Thai adults. Journal of Antiviral Therapy and Clinical Outcomes, 21(4), 220–229.
Author(s) unspecified. (2025). Efficacy and safety of tenofovir and lamivudine in combination with efavirenz in HIV/HBV co‑infected, treatment‑naïve individuals. Manuscript (ClinicalTrials.gov: NCT01751555).
Pujari, S., Sharma, V., Gupta, R., & Khan, M. (2024). Incidence and pattern of adverse drug reactions to first‑line antiretroviral therapy (tenofovir, lamivudine, and efavirenz): A prospective study in India. Indian Journal of Clinical Pharmacy, 15(2), 45–53.
cipla
Written By
Venika Choudhary
Medical Content Writer @ Magicine Pharma
I hold an M.Sc. in Microbiology and have a strong academic foundation in microbial sciences and applied biotechnology. I began my career with extensive hands-on research at CSIR laboratories, focusing on fungal enzyme production, studying fungal diversity in various ecosystems, and developing bio-pesticides as sustainable alternatives to chemical pesticides. This work deepened my understanding of fungal biology, bioactive compounds, and their pharmaceutical and agricultural applications. Transitioning from research, I now work as a medical content writer, where I combine my scientific expertise with a passion for clear and reliable healthcare communication. I apply my research background to create patient-friendly, compliant content for pharmaceutical companies and healthcare platforms, ensuring science is both trustworthy and accessible. Specializing in clear, accurate, and engaging content, I help patients make informed decisions and support pharmaceutical companies in delivering trusted information. Whether writing product descriptions, crafting disease awareness articles, or composing drug information leaflets, I consistently meet regulatory standards and address audience needs, making my content an asset for healthcare brands.
Reviewed By
Dr. Aditya Sarin - MBBS, MD, DrNB - Consultant Medical Oncology
Dr. Aditya Sarin, MBBS, MD, DrNB, is a highly qualified medical oncologist with profound research and clinical expertise, currently working at Sir Ganga Ram Hospital, New Delhi. He is also a member of the European Society of Medical Oncology (ESMO), a non-profit European organization dedicated to eradicating cancer by promoting comprehensive cancer care and advancing medical oncology. He has been honored with several awards, including the International Cancer Foundation scholarship (ESMO congress, 2022) and Young Medical Oncologist of the Year (Times of India, 2024). He is well-known for his breakthrough in oncology. Dr. Sarin is passionate about converting complex health information into a concise and clear form that is understandable to everyone, aiming to create awareness and cancer care among people.